Chemtai Mungo, MD, MPH, FACOG
Assistant Professor, Department of Obstetrics and Gynecology
Areas of Interest
Secondary prevention of cervical cancer in LMICs, self-administered therapies for HPV and cervical precancer treatment, AI-supported health education, women living with HIV
About
Awards and Honors
- NCI-Division of Cancer Prevention (DCP) Early Career Scientist (2023-2024)
- Daniel Von Hoff Innovative Protocol Award, ASCO/AACR Methods in Clinical Research Workshop, July 2023
- Golden Tar Heel Teaching Award, University of North Carolina, Chapel Hill
- Gilead HIV Scholars Award (2023-2025)
- American Association of Cancer Research Next Generation Star (2023)
Memberships
- 2021-present: International Papillomavirus Society
- Society 2021-present: Associate Member, UNC Lineberger Cancer Center
- 2021-present: Fellow, American College of Obstetrics and Gynecology
- 2019-present: Member, Cervical Cancer Prevention Technical Working Group, Kisumu County, Kenya
- 2019-present: Member, Kenya Obstetrics and Gynecology Society (KOGS)
In the News
-
Mungo Named Robert A. Winn Career Development Award Scholar
Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases and assistant professor of Obstetrics and Gynecology has been selected for the “Robert A. Winn Excellence in Clinical Trials: Career Development Award” (Winn CDA), a prestigious two-year national program that trains early-career physicians to design and lead community-centered clinical … Read more
-
Mungo Receives $2.5M to Improve HPV Treatment Outcomes in Women Living with HIV
Chemtai Mungo, MD, MPH, FACOG, has been awarded $2.5M over five years by the National Institutes of Health for her research focused on improving human papillomavirus (HPV) treatment outcomes in women living with HIV (WWH) in Africa. Dr. Mungo is an Assistant Professor in the UNC Department of Obstetrics and Gynecology, Affiliate Faculty in Lineberger … Read more
-
Pharmacokinetics of Intravaginal, Self-Administered Artesunate Vaginal Pessaries Among Women in Kenya
Cervical cancer remains a significant global health issue, especially in low- and middle-income countries (LMICs) where access to prevention and treatment is limited, and women are at a higher risk of cervical cancer. Artesunate, a widely available drug used to treat malaria, has shown promise in treating human papillomavirus (HPV)-associated anogenital lesions, including high-grade cervical … Read more
-
Chemtai Mungo Awarded ASCO Career Development Award for Cervical Cancer Research
Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases has been awarded the American Society of Clinical Oncology (ASCO) Career Development Award to support her research on the role of the vaginal microbiome in treatment outcomes following self-administered artesunate in the R34 trial she is conducting. Dr. Mungo previously received … Read more
-
Undergraduate
University of California Berkeley
-
Doctor of Medicine
University of California San Francisco School of Medicine
-
MPH
Johns Hopkins Bloomberg School of Public Health
-
Obstetrics & Gynecology Residency
Kaiser Foundation Hospital, San Francisco, CA
-
Global Health Fellowship
University of California San Francisco